Experience of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma and relapsed/refractory systemic anaplastic large-cell lymphoma in the Named Patient Program: Review of the literature
| Image |  |
|---|---|
| Description | scientific article published on 27 April 2015 |
| Author/s |
author: Pier Luigi Zinzani John Radford |
| Publication date | April 27, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |